MedPath

se of Sildenafil Citrate in the Management of Unexplained Infertility in Kisangani, Democratic Republic of Congo

Phase 3
Conditions
Fertility-female
Registration Number
PACTR202310849449401
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Female
Target Recruitment
144
Inclusion Criteria

Women aged 19-34, whose infertility tests were normal then diagnosed as unexplained infertility.
Informed (written) consent to participate in the study.

Exclusion Criteria

Any cause of infertility (male factors, tubal or ovarian factors, or any other factors)
Chronic illness as cardiac or renal disease
Any contraindication for used drugs
Refusal to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Conception rate (clinical pregnancy)
Secondary Outcome Measures
NameTimeMethod
Thickness and echogenicity of the endometrium <br>Velocity of uterine blood flow (pulsatility index and resistance index) <br>Number of mature follicles <br>Ovulation rate
© Copyright 2025. All Rights Reserved by MedPath